MAY 07, 2018 10:00 AM EDT

Managing CMV Infection and Realizing Operational Efficiencies in your Laboratory

Speakers
  • Senior Staff, Infectious Diseases Division at Henry Ford Health System, and Clinical Associate Professor of Infectious Diseases, Wayne State University in Michigan
    Biography
      Dr. John Ernest McKinnon is a senior staff in the Infectious Diseases Division at Henry Ford Health System and a Clinical Associate Professor of Infectious Diseases at Wayne State University in Detroit, Michigan. His research includes work on HIV, HIV viremia, HIV resistance, CMV infection in immunosuppressed patients including the current work on CMV resistance studies the impact of mutations on PCR amplification and detection of CMV viremia. Additional research focuses in the predictors of infectious complications and impact of opportunistic infections such as CMV in immunosuppressed populations, in patients receiving immunosuppressive therapy with autoimmune disorders and hematogenous stem cell transplants. Dr. McKinnon serves a member of the Institutional Review Board, Provider Advisory Council and on other committees at Henry Ford Hospital.
    • Professor & Vice Chair, Laboratory Medicine, and Medical Director of Clinical Laboratories & Molecular Pathology, Medical University of South Carolina
      Biography
        Dr. Frederick (Rick) S. Nolte is currently Professor and Vice Chair for Laboratory Medicine in the Department of Pathology and Laboratory Medicine, and Medical Director of Clinical Laboratories and Molecular Pathology at the Medical University of South Carolina. He is active in and held positions of responsibility in the American Society for Microbiology, Association for Molecular Pathology, Clinical and Laboratory Standards Institute, Infectious Diseases Society of America, American Society for Clinical Pathology, American Association for Clinical Chemistry, and College of American Pathologists. He has authored numerous book chapters, practice guidelines, and more than 100 peer-reviewed publications in the areas of clinical microbiology and molecular diagnostics.

      Abstract

      BROADCASTING on location at the Clinical Virology Symposium

      Our first presenter, Dr. John McKinnon, will be presenting on:

      CLINICAL IMPACT OF MISSING CMV VIREMIA IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS

      Human cytomegalovirus (CMV) infection is prevalent in transplant patients, and is frequently associated with significant morbidity and mortality. In CMV positive recipients of allogeneic human stem cell transplantation, the incidence of viral reactivation can be seen in up to 80% of patients, with up to 30% of these patients ultimately developing clinically significant CMV disease.1 The potential clinical impact of missing CMV viremia cannot be understated. In the first part of this presentation, Dr. John McKinnon will present data from his study comparing two commercial assays for the quantitation of CMV and potential relationship with mutations on UL54.  

      Learning Objectives:

      • Review of the current recommendations for CMV viral load monitoring in patients undergoing hematopoietic stem cell transplantation
      • Clinical study results of comparing two commercial assays for CMV viremia and genotypic resistance testing of samples with CMV viremia.
      • Clinical implications for our site and potential approaches to management of suspected CMV viremia.

      Our second presenter, Dr. Frederick (Rick) Nolte, will be presenting on:

      STREAMLINING AND STANDARDIZING MOLECULAR TESTING THROUGH CONSOLIDATION

      Consolidation of laboratory testing on a single automated molecular platform can result in many benefits to the laboratory, namely by reducing the number of redundant instruments, streamlining operations, and standardizing testing – all of which may translate into considerable cost savings and improved operational efficiency. In the second part of this presentation, Dr. Rick Nolte presents his experience with consolidating IVDs and LDTs on a versatile molecular platform.

      Learning Objectives:

      • Discuss the key factors to consider in selecting a molecular diagnostic test platform
      • Describe our experience with consolidation of LDTs and IVDs on the Abbott m2000 platform
      • Highlight the operational efficiencies that can be achieved through Lean laboratory design and the use of middleware in molecular diagnostic laboratories

       

      1 J.E. McKinnon et al. Comparison of Roche and Abbott Cytomegalovirus Quantitative PCR Assays in Allogeneic Hematopoietic Cell Transplant Recipients. Poster presented at IDWeek, October 4-8, 2017, San Diego, CA


      Show Resources
      You May Also Like
      MAY 11, 2021 10:00 AM PDT
      C.E. CREDITS
      MAY 11, 2021 10:00 AM PDT
      Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
      NOV 18, 2020 8:00 AM PST
      C.E. CREDITS
      NOV 18, 2020 8:00 AM PST
      DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
      APR 01, 2021 8:00 AM PDT
      C.E. CREDITS
      APR 01, 2021 8:00 AM PDT
      Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
      APR 21, 2021 10:00 AM PDT
      C.E. CREDITS
      APR 21, 2021 10:00 AM PDT
      Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
      APR 08, 2021 11:00 AM PDT
      C.E. CREDITS
      APR 08, 2021 11:00 AM PDT
      Date: April 8, 2021 Time: 11:00am (PDT), 3:00pm (EDT) Pneumonia is a deadly condition with clinical outcomes highly dependent on prompt and appropriate therapy. Diagnosis of pneumonia is cha...
      MAR 18, 2021 8:00 AM PDT
      C.E. CREDITS
      MAR 18, 2021 8:00 AM PDT
      DATE: March 18, 2021 TIME: 8:00am PDT Sequencing of bulk cells, single cells, and nuclei is opening doors in the understanding of complex biological processes....
      MAY 07, 2018 10:00 AM EDT

      Managing CMV Infection and Realizing Operational Efficiencies in your Laboratory


      Specialty

      Laboratory Testing

      Microbiology

      Infectious Disease

      Immunology

      Clinical Diagnostics

      Molecular Diagnostics

      Clinical Chemistry

      Molecular Biology

      Biochemistry

      Antibodies

      Hematology

      Virology

      Cancer Research

      Diagnostics

      Cancer Diagnostics

      Geography

      North America77%

      Asia10%

      Europe9%

      South America3%

      Oceania1%

      Africa1%

      Registration Source

      Website Visitors57%

      Email Promotions26%

      WAVE Newsletter Promotion16%

      Website Banners1%

      Social Media Promotions1%

      Job Title

      Medical Laboratory Technician29%

      Clinical Laboratory Scientist13%

      Lab Management11%

      Facility/Department Manager10%

      Medical Doctor/Specialist8%

      Executive8%

      Student6%

      Research Scientist5%

      Educator/Faculty4%

      Scientist4%

      Microbiologist3%

      Chemist1%

      QC/QA1%

      Organization

      Hospital26%

      Clinical Laboratory21%

      Medical Center9%

      Academic Institution8%

      Government4%

      Biotech Company4%

      Ambulatory Care3%

      Research Institute3%

      Medical Device Company2%

      Medical School2%

      Life Science Company2%

      Non-Profit Organization1%

      Pharmaceutical Company1%

      Diagnostic Company1%

      Other6%


      Show Resources
      Loading Comments...
      Show Resources
      Attendees
      • See more